Delayed, transient and self-resolving neutropenia following COVID-19 pneumonia.

COVID-19 haematology (drugs and medicines) haematology (incl blood transfusion) infectious diseases medical management

Journal

BMJ case reports
ISSN: 1757-790X
Titre abrégé: BMJ Case Rep
Pays: England
ID NLM: 101526291

Informations de publication

Date de publication:
12 May 2021
Historique:
entrez: 13 5 2021
pubmed: 14 5 2021
medline: 15 5 2021
Statut: epublish

Résumé

A novel coronaravirus, identified as SARS-CoV-2, spread throughout the world in 2020. The COVID-19 pandemic has led to many discoveries and clinical manifestations. A young patient is presented with new, self-resolving neutropenia presenting weeks after a prolonged hospital stay for COVID-19 pneumonia. Workup included analysis for underlying infection, nutritional abnormalities, malignancy, medication and toxin exposure, all of which were negative. From 2020 to the present, few reports have described neutropenia associated with a recent COVID-19 infection. In particular, no reports have described a delayed presentation of neutropenia. The authors would like to propose that the significant inflammatory response associated with COVID-19 is likely what led to this patient's postviral neutropenia. Furthermore, in young healthy patients, bone marrow biopsy may be deferred and a watchful-waiting approach may be taken to assess for neutropenia resolution.

Identifiants

pubmed: 33980567
pii: 14/5/e242596
doi: 10.1136/bcr-2021-242596
pmc: PMC8117979
pii:
doi:

Types de publication

Journal Article Case Reports

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© BMJ Publishing Group Limited 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Emerg Microbes Infect. 2020 Dec;9(1):221-236
pubmed: 31987001
Respir Med Case Rep. 2020;31:101231
pubmed: 32999856
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Clin Case Rep. 2020 Oct 26;8(12):3349-3351
pubmed: 33363932
Baillieres Clin Haematol. 1989 Jan;2(1):51-67
pubmed: 2537667
Pharmacotherapy. 2020 May;40(5):416-437
pubmed: 32259313
West J Med. 2000 Apr;172(4):248-52
pubmed: 10778379
Ther Adv Psychopharmacol. 2020 Jun 22;10:2045125320935306
pubmed: 32612804
Lancet. 2020 Mar 28;395(10229):1033-1034
pubmed: 32192578
Hematol Oncol Clin North Am. 1987 Jun;1(2):167-83
pubmed: 2888747
Circulation. 1998 Nov 24;98(21):2307-13
pubmed: 9826319
Ann Hematol. 2020 Jun;99(6):1205-1208
pubmed: 32296910
Open Forum Infect Dis. 2021 Jan 18;8(2):ofab017
pubmed: 33604404
Ann Oncol. 2020 Oct;31(10):1418-1419
pubmed: 32615155
Elife. 2021 Mar 16;10:
pubmed: 33724185

Auteurs

Victoria Marie Ferreira Mank (VMF)

Internal Medicine, Tripler Army Medical Center, Honolulu, Hawaii, USA victoriammank@gmail.com.

Jeffrey Mank (J)

University of New England, Biddeford, Maine, USA.

Jenie Ogle (J)

Internal Medicine, Tripler Army Medical Center, Honolulu, Hawaii, USA.

Jefferson Roberts (J)

Rheumatology, Tripler Army Medical Center, Honolulu, Hawaii, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH